Relmada Therapeutics Inc (NASDAQ:RLMD) jumps 64.15% In 2025; How Attractive Is It At $0.27?
In last trading session, Relmada Therapeutics Inc (NASDAQ:RLMD) saw 0.38 million shares changing hands with its beta currently measuring 0.19. Company’s recent per share price